239 results · 16ms · Sources: EU EUDAMED, US FDA

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market